Navigation Links
Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs

ARLINGTON, Va., Dec. 9 /PRNewswire-USNewswire/ -- John M. Gray, President and Chief Executive Officer of the Healthcare Distribution Management Association (HDMA), issued the following statement in reaction to Senate Amendment 2793 to the Patient Protection and Affordable Care Act, which would allow for importation of prescription medications:

"Importation of prescription drugs from foreign countries, as Senator Dorgan and others propose to allow, would compromise the secure U.S. distribution system by increasing the likelihood of entry for counterfeit or adulterated medicines. Efforts to sell counterfeit or adulterated medications produced overseas have become far more sophisticated in just the past few years. Rather than exposing U.S. patients to such risks, Congress should enhance the safety and security of the domestic supply chain through enactment of a uniform federal pedigree standard.

"We are very concerned about provisions in the legislation which call for implementation of a track-and-trace system by 2012. While this effort to address patient safety is well-intentioned, it is not aligned with industry capabilities, technological developments, or federal guidance on product serialization. States that have looked at track-and-trace issues in depth understand the complexity of such an undertaking. That is why the most aggressive time horizons established by states for track-and-trace implementation begin in 2015.

"HDMA and its members support the enhancement of pharmaceutical supply chain security through establishment of a uniform federal pedigree standard. This would facilitate the flow of prescription medicines between states and enable manufacturers, distributors, pharmacies, regulators and law enforcement to identify and prevent the entry of illicit products into our drug supply.

"Before opening our borders, a realistic, comprehensive approach is needed to counter these threats, facilitate interstate commerce and reconcile inconsistencies among the patchwork of state requirements currently in place. Importation is and will be an unsound policy until these issues are addressed."

To learn more about HDMA's position on importation, health reform and other issues, visit

About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link in the healthcare system. Each business day, HDMA member companies ensure that more than nine million prescription medicines and healthcare products are safely delivered to more than 165,000 pharmacies, hospitals, nursing homes, physician offices, clinics and others nationwide. HDMA and its members work daily to provide value and contain costs, saving the nation's healthcare system an estimated $32 billion per year. For more information, visit

SOURCE Healthcare Distribution Management Association

SOURCE Healthcare Distribution Management Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment
2. Natural Products Association Issues Statement on DEAs Steroid Classification Action
3. AAHSA Statement on Passage of Bennet Health Reform Amendment
4. Natural Products Association Issues Statement on New Supplement Safety Campaign
5. Statement of Support: Strengthening Oral Health Care is Key Part of Health Reform
6. Democratic National Committee Chairman Tim Kaines Statement on the Senates Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation
7. Statement by the Scientific Advisory Board of the Patient Advocate Foundation/National Patient Advocate Foundation on Changes to the USPSTF Mammography Guidelines
8. Pelosi Statement on House Passage of Medicare Physician Payment Reform Act
9. Democratic National Committee Chairman Issues Statement Praising the Patient Protection and Affordable Care Act
10. Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the New Senate Health Reform Bill
11. Pelosi Statement on Senate Health Insurance Reform Bill
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... discuss bioavailability and the need to integrate dose form selection in early phase ... OBN, the membership organization supporting and bringing together the UK’s emerging life sciences ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... and wellness consultation, has collaborated with Women’s Web – an online resource ... on topics on mental and emotional well-being relationship, life balance, stress, professional ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Finnleo, a ... Christmas Eve on several models of traditional and far-infrared saunas. , For ... Spruce is the most traditional Finnish sauna wood, and Finnleo uses only European Grade ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 10, 2015, Bohrer Brady, LLC filed ... on behalf of a home health care worker who provided companionship services for the ... care workers employed by Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials of ... Narconon network, announced the release of a new cutting edge recovery program that has ... been working with drug- and alcohol-addicted individuals with the purpose to free addicts from ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
(Date:11/25/2015)... 25, 2015 ... the "Global Brain Monitoring Devices Market ... --> ) has announced the ... Devices Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology: